Spot specimen testing with GeneXpert MTB/RIF results compared to morning specimen in a programmatic setting in Cotonou, Benin

Spot specimen testing with GeneXpert MTB/RIF results compared to morning specimen in a programmatic setting in Cotonou, Benin

Abstract Background The diagnosis of tuberculosis (TB) using smear microscopy has been based on testing two specimens: one spot and one early morning sputa. Recently, the World Health Organization (WHO) has recommended to replace, whenever possible, microscopy with GeneXpert® MTB/RIF performed on a...

Full description

Bibliographic Details
Main Authors: Faridath Massou, Merlin Fandohan, Ablo Prudence Wachinou, Schadrac Christin Agbla, Gildas Agodokpessi, Leen Rigouts, Bouke Catherine de Jong, Dissou Affolabi
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Infectious Diseases
Subjects:
GeneXpert® MTB/RIF
Screening strategy
Specimens
Online Access:https://doi.org/10.1186/s12879-021-06676-6

Internet

https://doi.org/10.1186/s12879-021-06676-6

Similar Items